Physician
Linthicum Pediatrics, LLC
Linthicum Pediatrics, LLC was paid $1.54M by Medicaid between Jan 2023 and Dec 2024, across 35 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 36% of everything it billed.
33Billing provider infoLINTHICUM PEDIATRICS, LLC
LINTHICUM, MD 21090
LINTHICUM, MD 21090
33aNPI1861132342assigned 03/31/2022
33bProvider typePediatrics Physician
28Total paid$1.54M
24GClaims43,300
24DCodes billed35
24AFirst – last monthJan 2023 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Maryland
Rank by total paid#71 of 306
Median peer was paid$206K
This provider vs. median7.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2023 | 20,869 | $715K | |
| 2024incomplete | 22,431 | $827K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 36% | 7,090 | 5,318 | $559K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 22% | 3,074 | 2,378 | $343K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 10% | 1,453 | 1,326 | $157K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 8.0% | 1,245 | 1,079 | $124K |
| 87428 | 3.3% | 2,239 | 1,424 | $51K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.1% | 446 | 415 | $47K |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 3.0% | 2,955 | 2,504 | $46K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 2.1% | 3,754 | 2,974 | $33K |
| 92587 | 2.0% | 1,803 | 1,649 | $30K | |
| 96160 | 1.5% | 7,838 | 5,143 | $22K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.4% | 2,100 | 1,429 | $22K |
| 90698 | <1% | 606 | 568 | $14K |
23 more codes
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 115 | $13K |
| 90686 | <1% | 599 | $13K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 109 | $12K |
| 90656 | <1% | 399 | $9K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 82 | $6K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 200 | $6K |
| 96127 | <1% | 1,209 | $6K | |
| 90677 | <1% | 229 | $5K | |
| 90670 | <1% | 221 | $5K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 79 | $3K |
| 90680 | <1% | 115 | $3K | |
| 96161 | <1% | 1,005 | $3K | |
| 99177 | <1% | 484 | $2K | |
| 94760 | <1% | 2,356 | $2K | |
| 87807 | <1% | 193 | $2K | |
| 90633 | <1% | 55 | $1K | |
| 99173 | <1% | 384 | $933.14 | |
| 90744 | <1% | 24 | $558.72 | |
| 85018 | <1% | 229 | $488.04 | |
| 99051 | <1% | 41 | $437.04 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 12 | $151.08 |
| 36416 | <1% | 545 | $63.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 12 | $0.60 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHILLIARD, JAIME (PRACTICE MANAGER)
| Provider | Location | Paid |
|---|---|---|
| Arundel Pediatrics, PA | Arnold, MD | $1.88M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.